Shinichiro Muraoka

Stock Analyst at Morgan Stanley

(1.15)
# 3,864
Out of 4,649 analysts
34
Total ratings
50%
Success rate
-2.4%
Average return

Stocks Rated by Shinichiro Muraoka

Sawai Group Holdings Co., Ltd.
Aug 12, 2026
Downgraded: Hold
Price Target: ¥2,000¥1,800
Current: ¥1,632
Upside: +10.29%
Takeda Pharmaceutical Company Limited
Jun 3, 2026
Reiterated: Buy
Price Target: ¥6,200¥6,300
Current: ¥5,611
Upside: +12.28%
Otsuka Holdings Co., Ltd.
Apr 30, 2026
Maintained: Buy
Price Target: ¥13,200¥14,100
Current: ¥12,030
Upside: +17.21%
Kyowa Kirin Co., Ltd.
Mar 6, 2026
Downgraded: Sell
Price Target: ¥1,700
Current: ¥2,580
Upside: -34.10%
Daiichi Sankyo Company, Limited
Nov 21, 2025
Maintained: Buy
Price Target: ¥4,750¥4,950
Current: ¥2,729
Upside: +81.39%
Sumitomo Pharma Co., Ltd.
Aug 22, 2025
Upgraded: Hold
Price Target: ¥1,350
Current: ¥1,372
Upside: -1.60%
SanBio Company Limited
Jul 2, 2025
Maintained: Hold
Price Target: ¥1,400¥2,100
Current: ¥1,043
Upside: n/a
Astellas Pharma Inc.
May 30, 2025
Maintained: Hold
Price Target: ¥1,750¥1,500
Current: ¥2,357
Upside: n/a
Shionogi & Co., Ltd.
May 30, 2025
Maintained: Hold
Price Target: ¥2,750
Current: ¥2,832
Upside: n/a
Eisai Co., Ltd.
May 29, 2025
Maintained: Hold
Price Target: ¥4,100
Current: ¥4,858
Upside: n/a
Maintained: Hold
Price Target: ¥3,900¥3,800
Current: ¥3,640
Upside: n/a
Maintained: Buy
Price Target: ¥7,650¥8,050
Current: ¥6,933
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $17.63
Upside: n/a